Supplement
Glutens clinical trials
Also written Gluten.
- studies test it
- 19
- open now
- 2
- in phase 3
- 1
- first study started
- 2008
Keep track of what changes. Save the Glutens studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Other names
- Gluten
- 14
Studies by the year they started
18 studies that test it; most in 2015 (4)
| Year | Studies |
|---|---|
| 2008 | 1 |
| 2009 | 2 |
| 2011 | 1 |
| 2013 | 1 |
| 2015 | 4 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2020 | 2 |
| 2022 | 1 |
| 2023 | 1 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 1
- Phase 2
- 1
- Phase 3
- 1
- No phase
- 16
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 4 · Other 15
Takeda (2) · Beth Israel Deaconess Medical Center (2) · Aarhus University Hospital (2) · Regeneron Pharmaceuticals (1) · Merck Sharp & Dohme LLC (1) · Thomas Jefferson University (1) · Uppsala University (1) · Mayo Clinic (1)
Often tested with
Tested in the same studies.
Cod (2) · TAK-101 (1) · Caseins (1) · Whey Proteins (1) · Gluten Free Diet (1)
Studies
Open first, then newest update. How each study uses Glutens is read from its arms, and is right about nine times in ten.
Testing it · 19
- Immune Responses to GlutenEnrolling by invitationNot applicableBoston Children's HospitalNCT05209568Written as Gluten Powder
- Single-cell Immune Response to Controlled Gluten Ingestion in Pediatric Celiac DiseaseRecruitingNot applicableFundación Pública Andaluza para la Investigación de Málaga en Biomedicina y SaludNCT07362654Written as Gluten 50 mg
- Dose-Ranging Study of the Efficacy and Safety of TAK-101 for Prevention of Gluten-Specific T Cell Activation in Participants With Celiac Disease on a Gluten-Free DietCompletedPhase 2TakedaNCT04530123Written as Gluten
- T Cell Receptor (TCR) Sequencing and Transcriptional Profiling in Adult Celiac Disease Patients Undergoing Gluten ChallengeCompletedNot applicableRegeneron PharmaceuticalsNCT04614571Written as Gluten Powder
- Gluten Challenge Study in Celiac Disease Participants (MK-0000-402)CompletedEarly Phase 1Merck Sharp & Dohme LLCNCT04054544Written as Gluten powder 4g
- Assessment of Immune Activation and Tolerance in Celiac Disease During Gluten ChallengeCompletedNot applicableTakedaNCT03409796Written as Gluten
- Serum Markers in Gluten ChallengeCompletedNot applicableBeth Israel Deaconess Medical CenterNCT00931892Written as Gluten
- Gluten Ingestion Biomarkers in Patients w Gluten Sensitivity and Healthy Controls Peptides in Patients With Non-celiac Gluten Sensitivity and Healthy Patients: A Placebo-controlled StudyCompletedNot applicableThomas Jefferson UniversityNCT02936297Written as High dose Gluten
- Identification of IBS Metabotypes Based on Physiological Responses to FoodCompletedNot applicableUppsala UniversityNCT03653689Written as Gluten
- Changes in Intestinal Permeability 4 Hours After Gluten ChallengeCompletedNot applicableMayo ClinicNCT03288831Written as Gluten
- Non Coeliac Gluten Sensitivity in ChildrenCompletedNot applicableCentre Hospitalier Universitaire de Saint EtienneNCT02895438Written as gluten
- Assessing Neurocognitive Effects of Gluten ExposureTerminatedNot applicableBeth Israel Deaconess Medical CenterNCT01506349Written as gluten
- Impact of the Restriction of Sources of Gluten in Fibromyalgia PatientsCompletedNot applicableFederal University of Minas GeraisNCT03129906Written as Gluten
- Infant Nutrition and Risk of Celiac DiseaseTerminatedNot applicableMassachusetts General HospitalNCT00819819Written as Gluten
- Gluten Sensitivity in Non-Celiac PatientsCompletedPhase 3University of Campania Luigi VanvitelliNCT01485341Written as gluten
- Symptomatic Response to Gluten Challenge in Patients With Suspected Non Celiac Gluten SensitivityCompletedNot applicableFondazione IRCCS Ca' Granda, Ospedale Maggiore PoliclinicoNCT01864993Written as gluten
- Prevalence of Gluten Sensitivity in Irritable Bowel Syndrome: The First Study in Paediatrics.Status unknownNot applicableUniversity of BariNCT02431585Written as gluten
- Acute Effects of Dietary Proteins on Postprandial Lipemia, Incretin Responses and Subclinical Inflammation in Obese SubjectsCompletedNot applicableAarhus University HospitalNCT00863564Written as Gluten
- Differential Effects of Protein Quality on Postprandial Lipemia in Response to a Fat-Rich Meal in Type 2 Diabetes: Comparison of Whey, Casein, Gluten, and Cod ProteinCompletedNot applicableAarhus University HospitalNCT00817973Written as Gluten
Given in every arm · 2 — Glutens is usual care beside what is tested
- Study of the Efficacy of Larazotide Acetate to Treat Celiac DiseaseCompletedPhase 29 Meters Biopharma, Inc.NCT00889473Written as Gluten 900 mg
- Study to Assess the Efficacy of Larazotide Acetate for the Treatment of Celiac DiseaseCompletedPhase 29 Meters Biopharma, Inc.NCT00492960Written as 900 mg gluten
As the comparator · 2 — what is tested is compared with Glutens
- Gfree - For Improved Blood Sugar and Reduced Inflammation.RecruitingNot applicableGöteborg UniversityNCT05894746Written as gluten
- Immunosafe-CeD: Are Partially Hydrolysed Gluten Harmful to Celiac Disease Patients?CompletedNot applicableOslo University HospitalNCT06151782Written as Wheat gluten 1000 mg
Codes
What other systems call Glutens · ClinicalTrials.gg INT007567
- MeSH (NLM) D005983GlutensConfirmed ClinicalTrials.gov, Wikidata
- UNII (FDA) 1534K8653JWHEAT GLUTENConfirmed FDA, Wikidata
- Wikidata Q188251glutenConfirmed FDA, Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D005983 | Glutens | Confirmed ClinicalTrials.gov, Wikidata |
| UNII (FDA) | 1534K8653J | WHEAT GLUTEN | Confirmed FDA, Wikidata |
| Wikidata | Q188251 | gluten | Confirmed FDA, Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.